within Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P03B_InsecticidesAndRepellents.P03BA02_Cypermethrin;

model Cypermethrin
  extends Pharmacolibrary.Drugs.ATC.P.P03BA02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>P03BA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cypermethrin is a synthetic pyrethroid insecticide widely used in agriculture and household pest control. It acts as a neurotoxin by disrupting sodium channel function in nerve cells of insects. While not approved for human therapeutic use, cypermethrin is prevalent as an antiparasitic agent for animals and is a common environmental contaminant in cases of pesticide poisoning.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for cypermethrin in humans after oral exposure, since no defined clinical PK models or published studies in humans are available. Data are roughly extrapolated from animal studies and general organophosphate/pyrethroid class literature.</p><h4>References</h4><ol><li><p>Chen, L, et al., &amp; Zhou, Z (2016). Distribution, Metabolism and Toxic Effects of Beta-Cypermethrin in Lizards (Eremias argus) Following Oral Administration. <i>Journal of hazardous materials</i> 306 87–94. DOI:<a href=\"https://doi.org/10.1016/j.jhazmat.2015.11.053\">10.1016/j.jhazmat.2015.11.053</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26698673/\">https://pubmed.ncbi.nlm.nih.gov/26698673</a></p></li><li><p>Yao, G, et al., &amp; Liu, D (2017). Enantioselective degradation of alpha-cypermethrin and detection of its metabolites in bullfrog (rana catesbeiana). <i>Ecotoxicology and environmental safety</i> 141 93–97. DOI:<a href=\"https://doi.org/10.1016/j.ecoenv.2017.03.019\">10.1016/j.ecoenv.2017.03.019</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28319864/\">https://pubmed.ncbi.nlm.nih.gov/28319864</a></p></li><li><p>Leng, G, et al., &amp; Selim, S (2006). Biomarker of pyrethrum exposure. <i>Toxicology letters</i> 162(2-3) 195–201. DOI:<a href=\"https://doi.org/10.1016/j.toxlet.2005.09.030\">10.1016/j.toxlet.2005.09.030</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16257148/\">https://pubmed.ncbi.nlm.nih.gov/16257148</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Cypermethrin;
